{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T13:30:35Z","timestamp":1762263035886,"version":"build-2065373602"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Otsuka Pharmaceutical Development & Commercialization, Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s12325-025-03345-x","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:30:18Z","timestamp":1757579418000},"page":"5612-5626","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Healthcare Costs Associated with Adverse Events in Pediatric Patients with Attention-Deficit\/Hyperactivity Disorder (ADHD): A Claims-Based Study"],"prefix":"10.1007","volume":"42","author":[{"given":"Jeff","family":"Schein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryaline","family":"Catillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana\u00efs","family":"Lemyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic","family":"Kinkead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjolaine","family":"Gauthier-Loiselle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Cloutier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Childress","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"key":"3345_CR1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425787","volume-title":"Diagnostic and statistical manual of mental disorders, fifth edition, text revision","author":"American Psychiatric Association","year":"2022","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fifth edition, text revision. Washington, DC: American Psychiatric Association; 2022."},{"key":"3345_CR2","first-page":"1","volume":"2024","author":"ML Danielson","year":"2024","unstructured":"Danielson ML, Claussen AH, Bitsko RH, Prevalence ADHD, et al. ADHD Prevalence among US children and adolescents in 2022: diagnosis, severity, co-occurring disorders, and treatment. J Clin Child Adolesc Psychol. 2024;2024:1\u201318.","journal-title":"J Clin Child Adolesc Psychol"},{"key":"3345_CR3","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-2528","author":"ML Wolraich","year":"2019","unstructured":"Wolraich ML, Hagan JF, Allan C, et al. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit\/hyperactivity disorder in children and adolescents. Pediatrics. 2019. https:\/\/doi.org\/10.1542\/peds.2019-2528.","journal-title":"Pediatrics"},{"issue":"2","key":"3345_CR4","first-page":"107","volume":"29","author":"LS Eiland","year":"2024","unstructured":"Eiland LS, Gildon BL. Diagnosis and treatment of ADHD in the pediatric population. J Pediatr Pharmacol Ther. 2024;29(2):107\u201318.","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"1","key":"3345_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/cap.2024.0061","volume":"35","author":"J Schein","year":"2024","unstructured":"Schein J, Cloutier M, Gauthier-Loiselle M, et al. Quality of life and outcomes associated with adverse effects in pediatric patients with attention-deficit\/hyperactivity disorder and their parents\/caregivers. J Child Adolesc Psychopharmacol. 2024;35(1):49\u201360.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"12","key":"3345_CR6","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.1007\/s12325-022-02329-5","volume":"39","author":"J Schein","year":"2022","unstructured":"Schein J, Cloutier M, Gauthier-Loiselle M, et al. Reasons for treatment changes in children and adolescents with attention-deficit\/hyperactivity disorder: a chart review study. Adv Ther. 2022;39(12):5487\u2013503.","journal-title":"Adv Ther"},{"issue":"1","key":"3345_CR7","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1186\/s12888-022-04188-4","volume":"22","author":"J Schein","year":"2022","unstructured":"Schein J, Childress A, Adams J, et al. Treatment patterns among children and adolescents with attention-deficit\/hyperactivity disorder in the United States\u2013a retrospective claims analysis. BMC Psychiatry. 2022;22(1):555.","journal-title":"BMC Psychiatry"},{"issue":"2","key":"3345_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jval.2023.11.002","volume":"27","author":"M Dodds","year":"2024","unstructured":"Dodds M, Wanni Arachchige Dona S, Gold L, et al. Economic burden and service utilization of children with attention-deficit\/hyperactivity disorder: a systematic review and meta-analysis. Value Health. 2024;27(2):247\u201364.","journal-title":"Value Health"},{"issue":"1","key":"3345_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/13696998.2022.2032097","volume":"25","author":"J Schein","year":"2022","unstructured":"Schein J, Adler LA, Childress A, et al. Economic burden of attention-deficit\/hyperactivity disorder among children and adolescents in the United States: a societal perspective. J Med Econ. 2022;25(1):193\u2013205.","journal-title":"J Med Econ"},{"key":"3345_CR10","volume-title":"120. Matching-adjusted indirect comparison of treatments for attention-deficit\/hyperactivity disorder in pediatric patients: a focus on short-term outcomes","author":"J Schein","year":"2024","unstructured":"Schein J, Catillon M, Lemyre A, et al. 120. Matching-adjusted indirect comparison of treatments for attention-deficit\/hyperactivity disorder in pediatric patients: a focus on short-term outcomes. Boston: Psych Congress; 2024."},{"issue":"1","key":"3345_CR11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1080\/13696998.2024.2342749","volume":"27","author":"J Schein","year":"2024","unstructured":"Schein J, Cloutier M, Bungay R, et al. Costs associated with adverse events during treatment episodes for adult attention-deficit\/hyperactivity disorder. J Med Econ. 2024;27(1):653\u201362.","journal-title":"J Med Econ"},{"issue":"1","key":"3345_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.22271\/oral.2023.v9.i1b.1657","volume":"9","author":"DAT Ornelas","year":"2023","unstructured":"Ornelas DAT, Vela MOR, Palencia PG. Xerostomia: etiology, diagnosis, prevalence, and treatment literature review. Int J Appl Dent Sci. 2023;9(1):75\u20139.","journal-title":"Int J Appl Dent Sci"},{"key":"3345_CR13","volume-title":"Statistical power analysis for behavioural sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis for behavioural sciences. 2nd ed. Oxfordshire: Routledge; 1988.","edition":"2"},{"key":"3345_CR14","unstructured":"US Bureau of Labor Statistics. Consumer price index: measuring price change in the CPI: medical care 2024. https:\/\/www.bls.gov\/cpi\/factsheets\/medical-care.htm"},{"issue":"1","key":"3345_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/pan\/mpr025","volume":"20","author":"J Hainmueller","year":"2012","unstructured":"Hainmueller J. Entropy balancing for causal effects: a multivariate reweighting method to produce balanced samples in observational studies. Polit Anal. 2012;20(1):25\u201346.","journal-title":"Polit Anal"},{"issue":"5","key":"3345_CR16","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1093\/aje\/kwaa244","volume":"190","author":"JW Sun","year":"2020","unstructured":"Sun JW, Bourgeois FT, Haneuse S, et al. Development and validation of a pediatric comorbidity index. Am J Epidemiol. 2020;190(5):918\u201327.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"3345_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196007","volume":"13","author":"W Wong","year":"2018","unstructured":"Wong W, Yim YM, Kim A, et al. Assessment of costs associated with adverse events in patients with cancer. PLoS ONE. 2018;13(4): e0196007.","journal-title":"PLoS ONE"},{"issue":"9","key":"3345_CR18","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S2215-0366(18)30269-4","volume":"5","author":"S Cortese","year":"2018","unstructured":"Cortese S, Adamo N, Del Giovane C, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5(9):727\u201338.","journal-title":"Lancet Psychiatry"},{"key":"3345_CR19","first-page":"1543","volume":"10","author":"K Gajria","year":"2014","unstructured":"Gajria K, Lu M, Sikirica V, et al. Adherence, persistence, and medication discontinuation in patients with attention-deficit\/hyperactivity disorder\u2014a systematic literature review. Neuropsychiatr Dis Treat. 2014;10:1543\u201369.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"8","key":"3345_CR20","first-page":"25","volume":"18","author":"KI Kamimura-Nishimura","year":"2019","unstructured":"Kamimura-Nishimura KI, Brinkman WB, Froehlich TE. Strategies for improving ADHD medication adherence. Curr Psychiatr. 2019;18(8):25\u201338.","journal-title":"Curr Psychiatr"},{"key":"3345_CR21","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.neubiorev.2020.09.031","volume":"120","author":"S Carucci","year":"2021","unstructured":"Carucci S, Balia C, Gagliano A, et al. Long term methylphenidate exposure and growth in children and adolescents with ADHD: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2021;120:509\u201325.","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"3345_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/jcpp.12036","volume":"54","author":"S Cortese","year":"2013","unstructured":"Cortese S, Holtmann M, Banaschewski T, et al. Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. J Child Psychol Psychiatry. 2013;54(3):227\u201346.","journal-title":"J Child Psychol Psychiatry"},{"issue":"1","key":"3345_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1515\/jpem-2015-0171","volume":"29","author":"F Gurbuz","year":"2016","unstructured":"Gurbuz F, Gurbuz BB, Celik GG, et al. Effects of methylphenidate on appetite and growth in children diagnosed with attention deficit and hyperactivity disorder. J Pediatr Endocrinol Metab. 2016;29(1):85\u201392.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"3345_CR24","unstructured":"World Health Organization (WHO). International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10)-WHO version\u2014general symptoms and signs 2019 [cited 2024]. https:\/\/icd.who.int\/browse10\/2019\/en#\/R68.0"},{"issue":"4","key":"3345_CR25","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.rdc.2021.07.008","volume":"47","author":"RL Randell","year":"2021","unstructured":"Randell RL, Lieberman SM. Unique aspects of pediatric Sjogren disease. Rheum Dis Clin North Am. 2021;47(4):707\u201323.","journal-title":"Rheum Dis Clin North Am"},{"issue":"5","key":"3345_CR26","first-page":"48","volume":"9","author":"L Walsh","year":"2007","unstructured":"Walsh L. Dry mouth: a clinical problem for children and young adults. Int Dent SA. 2007;9(5):48\u201358.","journal-title":"Int Dent SA"},{"issue":"4","key":"3345_CR27","volume":"16","author":"S Mhatre","year":"2024","unstructured":"Mhatre S, Srichand R, Sethumadhavan J, et al. Dry mouth dilemma: a comprehensive review of xerostomia in complete denture wearers. Cureus. 2024;16(4): e58564.","journal-title":"Cureus"},{"issue":"10","key":"3345_CR28","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11916-020-00892-6","volume":"24","author":"V Nieswand","year":"2020","unstructured":"Nieswand V, Richter M, Gossrau G. Epidemiology of headache in children and adolescents-another type of pandemia. Curr Pain Headache Rep. 2020;24(10):62.","journal-title":"Curr Pain Headache Rep"},{"issue":"5","key":"3345_CR29","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1001\/jamapediatrics.2020.5680","volume":"175","author":"SB Turner","year":"2021","unstructured":"Turner SB, Szperka CL, Hershey AD, et al. Association of headache with school functioning among children and adolescents in the United States. JAMA Pediatr. 2021;175(5):522\u20134.","journal-title":"JAMA Pediatr"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03345-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03345-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03345-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T13:24:54Z","timestamp":1762262694000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03345-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["3345"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03345-x","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"type":"print","value":"0741-238X"},{"type":"electronic","value":"1865-8652"}],"subject":[],"published":{"date-parts":[[2025,9,11]]},"assertion":[{"value":"8 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jeff Schein is an employee of Otsuka Pharmaceutical Development & Commercialization. Martin Cloutier, Marjolaine Gauthier-Loiselle, Maryaline Catillon, Ana\u00efs Lemyre, Alice Qu, and Frederic Kinkead are employees of Analysis Group, Inc., a consulting company that has provided paid consulting services to Otsuka Pharmaceutical Development & Commercialization, Inc, which funded the development and conduct of this study and manuscript. Ann Childress received research support from Aardvark, Allergan, Axsome, Emalex, Akili, Cingulate, Corium, Ironshore, Les Laboratoires Servier, Lumos, Neurocentria, Otsuka, Purdue, Adlon, Sunovion, Tris, KemPharm, and Supernus; was on the advisory board of Corium, Otsuka, Tris, and Supernus; received consulting fees from Aardvark, Alora, Axsome, Aytu, Cingulate, Corium, Lumos, Medison Pharma, Neurocentria, Noven, Otsuka, Sky, Tris, KemPharm, Supernus, and Tulex; received speaker fees from Takeda, Corium, Ironshore, Tris, and Supernus; and received writing support from Otsuka, Takeda, Corium, Ironshore, Purdue, and Tris.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was considered exempt research under 45 CFR \u00a7 46.104(d)(4) as it involved only the secondary use of data that were de-identified in compliance with the Health Insurance Portability and Accountability Act (HIPAA), specifically, 45 CFR \u00a7 164.514.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}